ArticleOphthalmology science2026
Lipidome's Role in Diabetic Retinopathy Subtypes via Inflammation: Mendelian Randomization and Mediation Analysis.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to explore the causal relationships between plasma lipidome, inflammatory cytokines, and diabetic retinopathy (DR) subtypes using a two-sample Mendelian randomization (MR) approach and mediation analysis. Design: Mendelian randomization study and mediation analysis. Subjects: Genome-wide association study (GWAS) data of 179 plasma lipid species and 91 inflammatory cytokines from the public GWAS database. Genome-wide association study data of DR and its subtypes from the FinnGen consortium. Methods: Primary causal estimates were derived via inverse-variance weighted method, complemented by 4 sensitivity methods (weighted median, MR-Egger, simple mode, weighted mode). Mediation analysis was performed to determine the extent to which inflammatory cytokines mediate the effects of lipid species on DR subtypes. The Cochran Q-test, MR-Egger intercept test, and leave-one-out were used for sensitivity analyses. Mendelian randomization-Egger regression and Mendelian Randomization Pleiotropy RESidual Sum and Outlier were used to detect potential directional pleiotropy. We employed a two-sample MR analysis to assess the causal effects of specific lipid species on the risk of DR and its subtypes. Genome-wide association study summary statistics for lipid species and inflammatory cytokines were used. Mediation analysis was performed to determine the extent to which inflammatory cytokines mediate the effects of lipid species on DR subtypes. Main Outcome Measures: Genetic causal associations between lipid species, inflammatory cytokines, and DR subtypes. Results: Mendelian randomization analyses showed that most of the identified plasma lipids were significantly protective against DR and its subtypes, mainly belonging to the phosphatidylcholine and phosphatidylethanolamine classes. Triacylglycerols have different roles in different severities of DR, and inflammatory cytokines had different causal effects on DR and its subtypes. Mediation analyses identified 10 specific inflammatory cytokine-mediated pathways of lipid species on DR, of which 7 had about 10% of the mediating effect, with inflammatory cytokines in the remaining 3 playing mediating effects opposite to the pathways. Conclusions: This study highlights the complex interplay between lipid metabolism and inflammation in the pathogenesis of DR. Specific lipid species protect against DR, with inflammatory cytokines mediating these effects, suggesting potential therapeutic targets for DR management. Financial Disclosures: The author has no/the authors have no proprietary or commercial interest in any materials discussed in this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.